$PCVX
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Healthcare
Sector
Biotechnology
Industry
Grant E. Pickering
CEO
414
Employees
$51.96
Current Price
$8.13B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 5 | $1,814,204.75 | 34,461 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 7 | $1,925,620.50 | 36,711 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 8 | $2,053,490.25 | 38,961 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 4 | 11 | $2,364,966.12 | 44,211 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | PICKERING GRANT Director | Sale | 1,000 | $52.50 | $52,500.00 | View Details |
| Jun 18, 2026 | PICKERING GRANT Director | Sale | 225 | $52.51 | $11,814.75 | View Details |
| Jun 18, 2026 | PICKERING GRANT Director | Sale | 1,000 | $52.50 | $52,500.00 | View Details |
| Jun 18, 2026 | PICKERING GRANT Director | Sale | 22,236 | $52.50 | $1,167,390.00 | View Details |
| Jun 18, 2026 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale | 10,000 | $53.00 | $530,000.00 | View Details |
| Jun 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 301 | $50.26 | $15,127.36 | View Details |
| Jun 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 1,949 | $49.40 | $96,288.40 | View Details |
| May 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 2,250 | $56.83 | $127,869.75 | View Details |
| Apr 7, 2026 | Cowan Elvia SVP, Finance & CAO | Sale | 3,000 | $60.00 | $180,000.00 | View Details |
| Apr 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 1,412 | $58.14 | $82,090.86 | View Details |
| Apr 1, 2026 | Wassil Jim CHIEF OPERATING OFFICER | Sale | 838 | $58.93 | $49,385.02 | View Details |
8 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history